A Texas woman is suing the makers of Eliquis, Bristol-Myers Squibb, after suffering an Eliquis bleeding injury.

Plaintiff Sherry S. was prescribed Eliquis, a popular anticoagulant, after being diagnosed with atrial fibrillation. Atrial fibrillation is a condition that can cause blood clots because blood pools in one of the upper chambers of the heart. Eliquis, generically known as apixaban, can help safeguard against blood clots that are a result of atrial fibrillation.

However, Sherry has suffered damages and is suing the drugmaker, Bristol-Meyers Squibb holding them responsible for her Eliquis bleeding injury.

Eliquis is a relatively new anticoagulant, having been introduced to the market in 2012. Its original intended use was to prevent stroke in patients with atrial fibrillation, like Sherry, and to also prevent blood clots in hip or knee surgery patients.

Eliquis stands shoulder-to-shoulder with other new anticoagulants, Pradaxa and Xarelto. All have similar uses and similar potential complications.

As with any blood thinning medication, Eliquis may need to be reversed at times so that bleeding can stop when needed. Eliquis, however, does not have a reversal agent available. In fact, blood thinners are ranked among the most dangerous medications to take because of how many adverse events are reported to the FDA.

Sherry only took Eliquis from April 2015 to May 2015. On April 14, 2015, Sherry was admitted to the hospital for difficulty breathing and was diagnosed with acute pulmonary edema, secondary to diastolic heart failure, as well as atrial fibrillation.

Because of this, she was directed by her doctors to take Eliquis. On April 24, she was discharged to a rehabilitation facility. However, on May 2, 2015, she returned to the hospital in respiratory distress and hypoxemia, or low blood oxygen.

On May 2, 2015, she was diagnosed with severe hematuria and a pleural effusion as a result of taking Eliquis.

Pleural effusion is a dangerous buildup of fluid around the lungs and hematuria is the presence of blood in the urine. Because of the pleural effusion, Sherry had to undergo surgery and was hospitalized for 18 days.

Sherry claims that she has suffered an Eliquis bleeding injury and holds Bristol-Meyers Squibb responsible. She alleges that she has endured and continues to incur medical expenses as well as suffer physical pain and mental anguish. She claims that she has suffered diminished enjoyment of life and other economic and non-economic damages.

According to Sherry’s Eliquis bleeding injury lawsuit, Bristol-Meyers Squib negligently manufactured and sold a drug while knowing it was dangerous and might result in an Eliquis bleeding injury for patients.

She brings forth claims of design defect and failure to warn, negligence and gross negligence, fraud and fraudulent concealment and breach of warranties.

This Eliquis Bleeding Injury Lawsuit is Case No. 3:17-cv-00957 in the United States District Court for the Northern District of Texas, Dallas Division.